Business

Notification of Interim Results

Notification of Interim Results.

articleFutura Medical PlcJuly 15, 20145/company/futura-medical-plc/news/notification-of-interim-results-27
Notification of Interim Results

About this update from Futura Medical Plc

[{"type":"text","content":"\n \nRNS Number : 2827M Futura Medical PLC 15 July 2014  \n \n\n\n\n\n\nFor immediate release\n\n\n15 July 2014\n\n\n\n\n \n \n \nFutura Medical plc\n(\"Futura\" or the \"Company\")\n \nNotice of Interim Results\n \nFutura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, will announce its interim results for the six months ended 30 June 2014 on Thursday 11  September 2014. \n \nA briefing for analysts will be held at 10.00am on the morning of the results at the offices of Buchanan, 107 Cheapside, London EC2V 6DN. \n \nThere will be a webcast of the analyst presentation. If you would like to listen to the webcast, please log on to the following web address approximately 5 minutes before 10.00am on the day of results: \nhttp://media.buchanan.uk.com/2014/futuramedical110914/registration.asp\nA recording of the webcast will also be made available at www.futuramedical.com and www.buchanan.uk.com, following the results meeting. \n \nFor more information, or to register attendance, please contact Buchanan on 020 7466 5000.\n \nFor any further information please contact:\n \n\n\n\n\nFutura Medical plc\n\n\n\n\n\n\n\nJames Barder, Chief Executive\n\n\nTel: +44 (0)1483 685 670\n\n\n\n\nmail to: [email protected]\n\n\nwww.futuramedical.com\n\n\n\n\n\n\n\n\n\n\n\n\nN+1 Singer (Nominated Adviser and Broker)\n\n\n\n\n\n\n\nAubrey Powell - Corporate Finance\nBrough Ransom - Sales\n\n\nTel:+44 (0) 20 7496 3000\n\n\n\n\n \n \n\n\n\n\n\n\n\nFor media enquiries please contact: \n\n\n\n\n\n\n\nBuchanan\n\n\n\n\n\n\n\nMark Court / Fiona Henson / Sophie Cowles\n\n\nTel: +44 (0)20 7466 5000\n\n\n\n\n \n \nNotes to Editors\n \nFutura Medical plc\n \nFutura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.\n \nFutura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.\n \nwww.futuramedical.com \n\nThis information is provided by RNSThe company news service from the London Stock Exchange  END  NOREAKXLFFXLEFF\n ","length":6776,...

More updates from Futura Medical Plc